Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Selling, General & Administrative (2017 - 2026)

Updated

Dianthus Therapeutics' Selling, General & Administrative was $8.2 million in Q3 2025, up 25.5% from $6.53 million a year earlier but down 7.6% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Selling, General & Administrative (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Dianthus Therapeutics' Selling, General & Administrative was $31.23 million through Sep 30, 2025, up 37.0% year-over-year; for FY2024, it came in at $24.99 million, up 37.6% from FY2023.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 1.0% (FY2019 to FY2024).
  • In earlier years, Selling, General & Administrative was $18.16 million in FY2023 (+169.3%), $6.74 million in FY2022 (-75.9%), $27.93 million in FY2021 (-0.6%) and $28.09 million in FY2020 (+18.2%).
  • Quarterly Selling, General & Administrative has moved between $2.04 million (Q4 2022) and $8.87 million (Q2 2025) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with growth averaging 67.2% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2023 (growth of 294.9%); the worst was Q4 2022 (a decline of 71.0%).
  • Per Business Quant data, DNTH's Selling, General & Administrative in the three quarters before Q3 2025 was $8.87 million (Q2 2025), $7.34 million (Q1 2025) and $6.83 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn - 14.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.08 Mn
Jun 30, 2026 13.56 Mn
Mar 31, 2026 12.47 Mn
Dec 31, 2025 9.93 Mn
Sep 30, 2025 8.20 Mn
Jun 30, 2025 8.87 Mn
Mar 31, 2025 7.34 Mn
Dec 31, 2024 6.83 Mn
Sep 30, 2024 6.53 Mn
Jun 30, 2024 6.00 Mn
Mar 31, 2024 5.64 Mn
Dec 31, 2023 4.63 Mn
Sep 30, 2023 8.72 Mn
Jun 30, 2023 2.49 Mn
Mar 31, 2023 2.31 Mn
Dec 31, 2022 2.04 Mn
Sep 30, 2022 2.21 Mn
Jun 30, 2022 6.48 Mn
Mar 31, 2022 7.29 Mn
Dec 31, 2021 7.03 Mn
API Access

Dianthus Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DNTH&period=max&api_key=YOUR_API_KEY